text size: A A

EU-US plans for joint funding of rare diseases research unveiled to industry

A new transatlantic alliance showcased its ambition to develop diagnostics for 8,000 rare diseases and double the number of registered Orphan drugs for rare conditions by 2020, according to reports from the Biotechnology Industry Organization meeting in Washington last week. Click here for the full story.